These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 16272705)

  • 1. Piperazine propanol derivative as a novel antifungal targeting 1,3-beta-D-glucan synthase.
    Kondoh O; Inagaki Y; Fukuda H; Mizuguchi E; Ohya Y; Arisawa M; Shimma N; Aoki Y; Sakaitani M; Watanabe T
    Biol Pharm Bull; 2005 Nov; 28(11):2138-41. PubMed ID: 16272705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of New Antifungal Agents Targeting Chitin Synthesis by a Chemical-Genetic Method.
    Li Y; Sun H; Zhu X; Bian C; Wang Y; Si S
    Molecules; 2019 Aug; 24(17):. PubMed ID: 31470665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emodin Reduces the Activity of (1,3)-
    Janeczko M
    Pol J Microbiol; 2018; 67(4):463-470. PubMed ID: 30550232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus.
    Satish S; Jiménez-Ortigosa C; Zhao Y; Lee MH; Dolgov E; Krüger T; Park S; Denning DW; Kniemeyer O; Brakhage AA; Perlin DS
    mBio; 2019 Jun; 10(3):. PubMed ID: 31164462
    [No Abstract]   [Full Text] [Related]  

  • 5. Differential expression and function of two homologous subunits of yeast 1,3-beta-D-glucan synthase.
    Mazur P; Morin N; Baginsky W; el-Sherbeini M; Clemas JA; Nielsen JB; Foor F
    Mol Cell Biol; 1995 Oct; 15(10):5671-81. PubMed ID: 7565718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arborcandins A, B, C, D, E and F, novel 1,3-beta-glucan synthase inhibitors: production and biological activity.
    Ohyama T; Kurihara Y; Ono Y; Ishikawa T; Miyakoshi S; Hamano K; Arai M; Suzuki T; Igari H; Suzuki Y; Inukai M
    J Antibiot (Tokyo); 2000 Oct; 53(10):1108-16. PubMed ID: 11132955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of novel antifungal (1,3)-beta-D-glucan synthase inhibitors.
    Onishi J; Meinz M; Thompson J; Curotto J; Dreikorn S; Rosenbach M; Douglas C; Abruzzo G; Flattery A; Kong L; Cabello A; Vicente F; Pelaez F; Diez MT; Martin I; Bills G; Giacobbe R; Dombrowski A; Schwartz R; Morris S; Harris G; Tsipouras A; Wilson K; Kurtz MB
    Antimicrob Agents Chemother; 2000 Feb; 44(2):368-77. PubMed ID: 10639364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of the Candida albicans homolog of Saccharomyces cerevisiae GSC1/FKS1 and its involvement in beta-1,3-glucan synthesis.
    Mio T; Adachi-Shimizu M; Tachibana Y; Tabuchi H; Inoue SB; Yabe T; Yamada-Okabe T; Arisawa M; Watanabe T; Yamada-Okabe H
    J Bacteriol; 1997 Jul; 179(13):4096-105. PubMed ID: 9209021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Paradoxical Effect of Echinocandins in Aspergillus fumigatus Relies on Recovery of the β-1,3-Glucan Synthase Fks1.
    Loiko V; Wagener J
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27872079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FKS1 mutations responsible for selective resistance of Saccharomyces cerevisiae to the novel 1,3-beta-glucan synthase inhibitor arborcandin C.
    Ohyama T; Miyakoshi S; Isono F
    Antimicrob Agents Chemother; 2004 Jan; 48(1):319-22. PubMed ID: 14693557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Saccharomyces cerevisiae mutant with echinocandin-resistant 1,3-beta-D-glucan synthase.
    Douglas CM; Marrinan JA; Li W; Kurtz MB
    J Bacteriol; 1994 Sep; 176(18):5686-96. PubMed ID: 8083161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of the FKS1 gene of Candida albicans as the essential target of 1,3-beta-D-glucan synthase inhibitors.
    Douglas CM; D'Ippolito JA; Shei GJ; Meinz M; Onishi J; Marrinan JA; Li W; Abruzzo GK; Flattery A; Bartizal K; Mitchell A; Kurtz MB
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2471-9. PubMed ID: 9371352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization and optimization of in vitro assay conditions for (1,3)beta-glucan synthase activity from Aspergillus fumigatus and Candida albicans for enzyme inhibition screening.
    Wood RL; Miller TK; Wright A; McCarthy P; Taft CS; Pomponi S; Selitrennikoff CP
    J Antibiot (Tokyo); 1998 Jul; 51(7):665-75. PubMed ID: 9727393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization and cilofungin inhibition of solubilized Aspergillus fumigatus (1,3)-beta-D-glucan synthase.
    Beaulieu D; Tang J; Yan SB; Vessels JM; Radding JA; Parr TR
    Antimicrob Agents Chemother; 1994 May; 38(5):937-44. PubMed ID: 8067773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a novel class of orally active antifungal beta-1,3-D-glucan synthase inhibitors.
    Walker SS; Xu Y; Triantafyllou I; Waldman MF; Mendrick C; Brown N; Mann P; Chau A; Patel R; Bauman N; Norris C; Antonacci B; Gurnani M; Cacciapuoti A; McNicholas PM; Wainhaus S; Herr RJ; Kuang R; Aslanian RG; Ting PC; Black TA
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5099-106. PubMed ID: 21844320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A glucan synthase FKS1 homolog in cryptococcus neoformans is single copy and encodes an essential function.
    Thompson JR; Douglas CM; Li W; Jue CK; Pramanik B; Yuan X; Rude TH; Toffaletti DL; Perfect JR; Kurtz M
    J Bacteriol; 1999 Jan; 181(2):444-53. PubMed ID: 9882657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SAR studies of pyridazinone derivatives as novel glucan synthase inhibitors.
    Zhou G; Ting PC; Aslanian R; Cao J; Kim DW; Kuang R; Lee JF; Schwerdt J; Wu H; Herr RJ; Zych AJ; Yang J; Lam S; Wainhaus S; Black TA; McNicholas PM; Xu Y; Walker SS
    Bioorg Med Chem Lett; 2011 May; 21(10):2890-3. PubMed ID: 21489787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caspofungin susceptibility in Aspergillus and non-Aspergillus molds: inhibition of glucan synthase and reduction of beta-D-1,3 glucan levels in culture.
    Kahn JN; Hsu MJ; Racine F; Giacobbe R; Motyl M
    Antimicrob Agents Chemother; 2006 Jun; 50(6):2214-6. PubMed ID: 16723587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, anti-fungal and 1,3-β-D-glucan synthase inhibitory activities of caffeic and quinic acid derivatives.
    Ma CM; Abe T; Komiyama T; Wang W; Hattori M; Daneshtalab M
    Bioorg Med Chem; 2010 Oct; 18(19):7009-14. PubMed ID: 20813534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current perspectives on echinocandin class drugs.
    Perlin DS
    Future Microbiol; 2011 Apr; 6(4):441-57. PubMed ID: 21526945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.